Key result
Wearables and AI show promise for heart disease screening but optimal target populations need evaluation.
Why the study?
Many people with heart disease are unaware of their condition, creating an opportunity to explore how emerging digital health technologies and augmented intelligence solutions can aid targeted screening.
Digital health technologies and augmented intelligence offer emerging opportunities for targeted screening of various heart diseases in specific populations.
May inform future screening strategies; leaves open optimal populations and prospective validation before clinical adoption.
Heart disease affects much of the world’s population, yet many people have no idea that they could have something wrong with them. An opportunity therefore exists for targeted screening for conditions such as cardiovascular disease, heart rhythm changes, valvular heart disease, structural abnormalities, and more subtle, rarer inherited heart conditions. At the same time, the rapid development of digital health technologies and clinical support systems is providing patients and their doctors access to augmented intelligence solutions to diagnose these conditions. This article will focus on how the emerging field of digital health technology can aid screening for heart disease and explore its usefulness in disease specific and population specific groups.
No takes yet. Share an insight, caveat, or question.
Richardson et al. (2022) conducted a review in Heart Disease. Digital health technologies vs. Traditional screening methods was evaluated. Digital health technologies, including wearables and artificial intelligence, offer promising new methods for heart disease screening, though optimal target populations require further evaluation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: